Activated prothrombin complex concentrate for reversal of oral factor Xa inhibitors at a level 1 trauma center

被引：1
|
作者：
Bobby, Lauren [1 ]
Westlake, Evan [1 ]
Esplin, Nathan [2 ]
Young, Sarah [1 ]
机构：
[1] Allegheny Gen Hosp, Dept Pharm, 320 North Ave, Pittsburgh, PA 15212 USA
[2] Allegheny Gen Hosp, Dept Neurosurg, 320 North Ave, Pittsburgh, PA 15212 USA
来源：
THROMBOSIS RESEARCH | 2021年 / 206卷
关键词：
Apixaban; Rivaroxaban; Reversal; Activated prothrombin complex concentrate (aPCC); Intracranial hemorrhage (ICH); Andexanet alfa; ANTICOAGULANTS; MANAGEMENT; OUTCOMES; FEIBA;
D O I：
10.1016/j.thromres.2021.08.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：33 / 35
页数：3
相关论文
共 50 条
  • [11] Reversal of oral factor Xa inhibitors by prothrombin complex concentrates: a re-appraisal
    Dzik, W. H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : S187 - S194
  • [12] Andexanet alfa or prothrombin complex concentrate for acute reversal of oral factor Xa inhibitors: monitoring of antidote effects
    Tanaka, Kenichi A.
    Levy, Jerrold H.
    BRITISH JOURNAL OF ANAESTHESIA, 2024, 132 (02) : 215 - 217
  • [13] Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective study
    Piran, Siavash
    Gabriel, Caroline
    Schulman, Sam
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (04) : 486 - 495
  • [14] Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study
    Schulman, Sam
    Gross, Peter L.
    Ritchie, Bruce
    Nahirniak, Susan
    Lin, Yulia
    Lieberman, Lani
    Carrier, Marc
    Crowther, Mark A.
    Ghosh, Indy
    Lazo-Langner, Alejandro
    Zondag, Michelle
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (05) : 842 - 851
  • [15] Cost-effectiveness of andexanet alfa versus four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-related intracranial hemorrhage in the US
    Fanikos, John
    Goldstein, Joshua N.
    Lovelace, Belinda
    Beaubrun, Anne C.
    Blissett, Robert S.
    Aragao, Filipa
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 309 - 320
  • [16] Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor-associated bleeding: Case series
    Liu, JiTong
    Elsamadisi, Pansy
    Philips, Eli
    Bauer, Kenneth A.
    Eche, Ifeoma M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (16) : 1323 - 1329
  • [17] The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
    Nina Haagenrud Schultz
    Hoa Thi Tuyet Tran
    Stine Bjørnsen
    Carola Elisabeth Henriksson
    Per Morten Sandset
    Pål Andre Holme
    Thrombosis Journal, 15
  • [18] Reversal of Warfarin-Associated Major Hemorrhage: Activated Prothrombin Complex Concentrate versus 4-Factor Prothrombin Complex Concentrate
    Peksa, Gary D.
    Mokszycki, Robert K.
    Rech, Megan A.
    Maynard, Brian
    Panos, Nicholas G.
    Sweis, Rolla T.
    DeMott, Joshua M.
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (02) : 207 - 215
  • [19] Comparison of high- and low-dose 4-factor prothrombin complex concentrate for the emergent reversal of oral Factor Xa inhibitors
    Hormese, Mary
    Littler, Alex
    Doane, Brian
    Glowacki, Nicole
    Khimani, Ann
    Vivacqua, Nicole
    Rudenberg, Karina
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (03) : 828 - 835
  • [20] Administration of 4-Factor Prothrombin Complex Concentrate as an Antidote for Intracranial Bleeding in Patients Taking Direct Factor Xa Inhibitors
    Grandhi, Ramesh
    Newman, W. Christopher
    Zhang, Xiaoran
    Harrison, Gillian
    Moran, Colleen
    Okonkwo, David O.
    Ducruet, Andrew F.
    WORLD NEUROSURGERY, 2015, 84 (06) : 1956 - 1961
12345